0001104659-24-001950.txt : 20240105 0001104659-24-001950.hdr.sgml : 20240105 20240105210114 ACCESSION NUMBER: 0001104659-24-001950 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240103 FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blok Tyler CENTRAL INDEX KEY: 0001990234 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 24518097 MAIL ADDRESS: STREET 1: 1111 MAIN STREET STREET 2: SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 tm242134-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-03 0 0001175680 CytoDyn Inc. CYDY 0001990234 Blok Tyler 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 0 1 0 0 EVP of Legal Affairs 0 Common Stock 250 I By Spouse Non-qualified stock option (right to buy) 0.67 2024-01-03 4 D 0 100000 D 2032-07-25 Common Stock 100000 0 D Non-qualified stock option (right to buy) 0.21 2024-01-03 4 A 0 100000 A 2032-07-25 Common Stock 100000 100000 D Non-qualified stock option (right to buy) 0.21 2024-01-03 4 A 0 1000000 0 A 2034-01-03 Common Stock 1000000 1000000 D 25% of the grant vested on July 25, 2023, with the balance vesting in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) beginning at the end of August 2023 through July 2026. The outstanding option was cancelled in exchange for a new option having a lower exercise price. 35,415 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through July 2026. 145,831 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through May 2027. /s/ Tyler Blok 2024-01-05